Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro
- PMID: 17234900
- DOI: 10.1124/jpet.106.116863
Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro
Abstract
Trace amine-associated receptor 1 (TAAR1) is a G protein-coupled receptor that directly responds to endogenous monoamines as well as amphetamine-related psychostimulants, including methamphetamine. In the present study, we demonstrate TAAR1 mRNA and protein expression in rhesus monkey brain regions associated with monoaminergic systems, variable cellular distribution of TAAR1 in rhesus monkey brain, and TAAR1 coexpression with the dopamine transporter (DAT) in a subset of dopamine neurons in both rhesus monkey and mouse substantia nigra. On this basis, we evaluated rhesus monkey TAAR1 activation by different compounds and its functional relation with monoamine transporters and the dopamine D2 receptor (D2) short isoform (D2s) autoreceptor in vitro using a cAMP response element-luciferase assay. TAAR1 activation by monoamines and amphetamine-related compounds was greatly enhanced by coexpression of dopamine, norepinephrine, or serotonin transporters, and the activation enhancement was blocked by monoamine transporter inhibitors. This enhancement did not occur in control experiments in which the dopamine D1 receptor (D1) was substituted for TAAR1. Furthermore, activation of TAAR1 by dopamine was completely inhibited by D2s when coexpressed with TAAR1, and this inhibition was blocked by the D2 antagonist raclopride. Last, dopamine activation of TAAR1 could induce c-FOS-luciferase expression but only in the presence of DAT, whereas dopamine activation of D1 resulted in equivalent c-FOS expression in the presence or absence of DAT. Together, these data reveal a broad agonist spectrum for TAAR1, a functional relation of TAAR1 with monoamine transporters and D2s, and a mechanism by which D2 receptor drugs can influence brain monoaminergic function and have efficacy through affecting TAAR1 signaling.
Similar articles
-
Trace amine-associated receptor 1 is a modulator of the dopamine transporter.J Pharmacol Exp Ther. 2007 Apr;321(1):128-36. doi: 10.1124/jpet.106.117382. Epub 2007 Jan 18. J Pharmacol Exp Ther. 2007. PMID: 17234899
-
Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.J Pharmacol Exp Ther. 2008 May;325(2):629-40. doi: 10.1124/jpet.107.135079. Epub 2008 Feb 29. J Pharmacol Exp Ther. 2008. PMID: 18310473
-
Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.J Neurosci Res. 2008 Nov 15;86(15):3435-46. doi: 10.1002/jnr.21783. J Neurosci Res. 2008. PMID: 18627029 Free PMC article.
-
The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.J Neurochem. 2011 Jan;116(2):164-76. doi: 10.1111/j.1471-4159.2010.07109.x. J Neurochem. 2011. PMID: 21073468 Free PMC article. Review.
-
[Alteration of neuronal activities following repeated administration of stimulants].Nihon Arukoru Yakubutsu Igakkai Zasshi. 2002 Feb;37(1):31-40. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2002. PMID: 11915303 Review. Japanese.
Cited by
-
A Pilot Study on a Possible Mechanism behind Olfactory Dysfunction in Parkinson's Disease: The Association of TAAR1 Downregulation with Neuronal Loss and Inflammation along Olfactory Pathway.Brain Sci. 2024 Mar 22;14(4):300. doi: 10.3390/brainsci14040300. Brain Sci. 2024. PMID: 38671952 Free PMC article.
-
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.Signal Transduct Target Ther. 2023 May 3;8(1):177. doi: 10.1038/s41392-023-01427-2. Signal Transduct Target Ther. 2023. PMID: 37137892 Free PMC article. Review.
-
Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson's Disease Therapy.Biomolecules. 2022 Dec 21;13(1):9. doi: 10.3390/biom13010009. Biomolecules. 2022. PMID: 36671394 Free PMC article.
-
Natural Sympathomimetic Drugs: From Pharmacology to Toxicology.Biomolecules. 2022 Nov 30;12(12):1793. doi: 10.3390/biom12121793. Biomolecules. 2022. PMID: 36551221 Free PMC article. Review.
-
Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum.Int J Mol Sci. 2022 Aug 1;23(15):8543. doi: 10.3390/ijms23158543. Int J Mol Sci. 2022. PMID: 35955676 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases